Fecal and blood samples were collected from 14 healthy donors whose CD34+ HSPCs have been transplanted into patients with acute myelocytic leukemia (AML), acute lymphocytic leukemia (ALL) or myelodysplastic syndromes (MDS) (Fig. 6a; Supplementary Table S4). This evidence concerns the gene CD34 and acute lymphoblastic leukemia.